Center for Translational Pathology Purchases Genomatix’ Next-Gen Sequencing Analysis Systems
The Center for Translational Pathology at the University of Michigan installed a Genomatix Mining Station (GMS) and a Genomatix Genome Analyzer (GGA) at its labs in Ann Arbor, MI. The two technologies work in conjunction to provide an analysis of next-generation sequencing data.
GMS is based on a genomic pattern recognition paradigm, or GenomeThesaurus, which allows for input of raw sequence reads plus optional quality files from any sequencing hardware. GGA delivers downstream software tools and databases for the analysis of GMS data.
GMS reportedly provides ultrafast mapping of sequences of any length (starting from 8 bp) with no practical limits on the number of point mutations and/or insertions and deletions that can be taken into account during the mapping process. Depending on the nature of the experiment, the GMS can provide SNP detection and genotyping, copy number analysis, and small RNA analysis.